sofosbuvir has been researched along with Dengue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colby-Germinario, SP; Fogarty, C; Han, Y; Hassounah, SA; Oliveira, M; Osman, N; Palanisamy, N; Quan, Y; Wainberg, MA; Xu, HT | 1 |
1 other study(ies) available for sofosbuvir and Dengue
| Article | Year |
|---|---|
Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication.
Topics: Antiviral Agents; Cell Line; Dengue; Dengue Virus; Drug Evaluation; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Sofosbuvir; Uridine Triphosphate; Viral Nonstructural Proteins; Virus Replication | 2017 |